Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
Background: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver diseases. In most cases, NAFLD progresses from benign steatosis to steatohepatitis (NASH), and then to cirrhosis. No treatment is currently approved for NAFLD/NASH in the clinic. Fenofibrate (FENO) has been c...
Saved in:
Main Authors: | Xinxue Wang (Author), Jia Luo (Author), Zhuoheng Lu (Author), Shenzhe Fang (Author), Mengxia Sun (Author), Wenjing Luo (Author), Jianwei Shen (Author), Aiming Liu (Author), Hua Ye (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is non-alcoholic steatohepatitis caused by alcohol?
by: Hubert E Blum
Published: (2020) -
Fructose and Non-Alcoholic Steatohepatitis
by: Elke Roeb, et al.
Published: (2021) -
Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet
by: Jing-hua Peng, et al.
Published: (2018) -
Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010) -
Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis
by: Wei Luo, et al.
Published: (2023)